Related references
Note: Only part of the references are listed.An ultrasensitive method for the quantitation of active and inactive GLP-1 in human plasma via immunoaffinity LC-MS/MS
Derek L. Chappell et al.
BIOANALYSIS (2014)
In Vitro Metabolism of the Glucagon-Like Peptide-1 (GLP-1)-Derived Metabolites GLP-1(9-36)amide and GLP-1(28-36)amide in Mouse and Human Hepatocytes
Raman Sharma et al.
DRUG METABOLISM AND DISPOSITION (2013)
GLP-1 receptor agonists: A clinical perspective on cardiovascular effects
Dhanwantee Mundil et al.
DIABETES & VASCULAR DISEASE RESEARCH (2012)
GLP-1 based therapies: differential effects on fasting and postprandial glucose
M. S. Fineman et al.
DIABETES OBESITY & METABOLISM (2012)
Cardiovascular Biology of the Incretin System
John R. Ussher et al.
ENDOCRINE REVIEWS (2012)
Therapy in the Early Stage: Incretins
Simona Cernea et al.
DIABETES CARE (2011)
Glucagon-Like Peptide-1 Increases Myocardial Glucose Uptake via p38α MAP Kinase-Mediated, Nitric Oxide-Dependent Mechanisms in Conscious Dogs With Dilated Cardiomyopathy
Siva Bhashyam et al.
CIRCULATION-HEART FAILURE (2010)
GLP-1 (9-36) Amide Metabolite Suppression of Glucose Production in Isolated Mouse Hepatocytes
E. Tomas et al.
HORMONE AND METABOLIC RESEARCH (2010)
Insulin-like actions of glucagon-like peptide-1: a dual receptor hypothesis
Eva Tomas et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2010)
The Extrapancreatic Effects of Glucagon-Like Peptide-1 and Related Peptides
Rania Abu-Hamdah et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Cardiovascular consequences of drugs used for the treatment of diabetes: potential promise of incretin-based therapies
Kiwon Ban et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2009)
Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways
Kiwon Ban et al.
CIRCULATION (2008)
GLP-1 (9-36) amide, cleavage product of GLP-1 (7-36) amide, is a glucoregulatory peptide
Dariush Elahi et al.
OBESITY (2008)
The physiology of glucagon-like peptide 1
Jens Juul Holst
PHYSIOLOGICAL REVIEWS (2007)
Active metabolite of GLP-1 mediates myocardial glucose uptake and improves left ventricular performance in conscious dogs with dilated cardiomyopathy
LA Nikolaidis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Mass spectrometry of peptides and proteins
VH Wysocki et al.
METHODS (2005)
Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy
LA Nikolaidis et al.
CIRCULATION (2004)
Share Paper
